FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose

Estimated reading time: 1 minutes

• About The Author

The U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto-injector for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older.

About The Author

See author's posts

Trending

The Ultimate Guide to Instagram Influencer Marketing for Brands